Skip to main content
Clinical Trials/CTRI/2018/06/014679
CTRI/2018/06/014679
Not yet recruiting
Phase 2

â??A Clinical Comparative Evaluation of Chitrakadi Churna With Vaitarana Basti and Devdarvyadi Churna With Vaitarana Basti Specifically on Disability Index Score of Amavata wsrt Rheumatoid Arthritisâ??

Government Ayurved college Nagpur0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Government Ayurved college Nagpur
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Government Ayurved college Nagpur

Eligibility Criteria

Inclusion Criteria

  • 1\) Patients having signs and symptoms of Amavata mentioned in Ayurvedic texts.
  • 2\) All patients fulfilling a score of 6/10 is needed for classification of a patient as having definite Rheumatoid Arthritis which is American criteria of rheumatoid arthritis (2010\). 3\) Patients of either sex aged between 30\-60 years.
  • 4\) Patient willing and able to participate in the study.
  • 5\) Patients who have not participated in any research projects since last 6 months.
  • 6\) Patients of rheumatoid arthritis having controlled hypertension and diabetes mellitus may also be included.
  • 7\) Patients of Aamvata having Sama Avastha will only be included in study.

Exclusion Criteria

  • 1\) Patients who are not willing for trial.
  • 2\) Patients having gross disability in performing daily normal routine i.e. bed ridden patients or confined to a wheelchair or have to take help to perform daily routine activity.
  • 3\) Patients having gouty arthritis, syphilitic arthritis, psoriatic arthritis, rheumatic arthritis, tubercular arthritis, gonococcal arthritis etc.
  • 4\) Patients with poorly controlled Hypertension (B.P. \> 160/100mmHg).
  • 5\) Patients with poorly controlled Diabetes Mellitus
  • (HBA1C 6\.5 to 10mmol/dl)
  • 6\) Patients with the evidence of malignancy.
  • 7\) Patients on prolonged medication ( \>6weeks) with corticosteroids, or any other drugs that may have an influence on the outcome of the study.
  • 8\) Patients who are currently participating in any other clinical trials (since last 6 months).
  • 9\) Any other conditions which the researcher thinks may jeopardize the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials